Functional Analysis of the c-myb Proto-Oncogene

  • H. H. Lin
  • D. C. Sternfeld
  • S. G. Shinpock
  • R. A. Popp
  • M. L. Mucenski
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 211)

Abstract

The v-myb gene was initially identified as the oncogenic agent in the defective avian myeloblastosis virus (AMV), which induces acute myeloblasts leukemia in vivo and transforms myeloid cells in vitro (1). Klempnauer et al. (2,3) showed that the v-myb portion of AMV was transduced from seven internal exons of a cellular gene designated c-myb. A second replication-defective avian retrovirus, E26, was also found to contain v-myb as well as v-ets sequences (4,5). As with AMV, E26 contains a v-myb component which is an altered version of c-myb, with each containing both amino- and carboxy-terminal truncations of their gene products. The proteins encoded by AMV, E26, and c-myb have been localized to the nucleus (6,7).

Keywords

Migration Lymphoma Leukemia Cysteine Anemia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Moscovici, C (1975) Leukemic transformation with avian myeloblastosis virus: present status. Curr Topics Microbiol Immunol 71:79–101Google Scholar
  2. 2.
    Klempnauer, KH, Gonda, TJ, Bishop, JM (1982) Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene. Cell 31:453–463PubMedCrossRefGoogle Scholar
  3. 3.
    Klempnauer, KH, Ramsay R, Bishop MJ, Moscovici MG, Moscovici C, McGrath JP, Levinson AD (1983) The product of the retroviral transforming gene v-myb is a truncated version of the protein encoded by the cellular oncogene c-myb. Cell 33:345–355PubMedCrossRefGoogle Scholar
  4. 4.
    Roussel M, Saule S, Lagrou C, Rommens C, Beug H, Graf T, Stehelin D (1979) Three types of viral oncogenes of cellular origin specific for hematopoietic cell transfomation. Nature 281:452–455PubMedCrossRefGoogle Scholar
  5. 5.
    Leprince D, Gegonne A, Coll J, de Taisne C, Schneeberger A, Lagrou C, Stehelin D (1983) A putative second cell-derived oncogene of the avian leukemia retrovirus E26. Nature 306:395–397PubMedCrossRefGoogle Scholar
  6. 6.
    Klempnauer KH, Symonds G, Evan GI, Bishop JM (1984) Subcellular localization of proteins encoded by oncogenes of avian myeloblastosis virus and avian leukemia virus E26 and by the chicken c-myb gene. Cell 37:537–547PubMedCrossRefGoogle Scholar
  7. 7.
    Boyle WJ, Lampert MA, Lipsick JS, Baluda MA (1984) Avian myeloblastosis virus and E26 virus oncogene products are nuclear proteins. Proc Natl Acad Sci USA 81:4265–4269PubMedCrossRefGoogle Scholar
  8. 8.
    Westin EH, Gallo RC, Arya SK, Eva A, Souza LM, Baluda MA, Aaronson SA, Wong-Staal F (1982) Differential expression of the amv gene in human hematopoietic cells. Proc Natl Acad Sci USA 79:2194–2198PubMedCrossRefGoogle Scholar
  9. 9.
    Gonda TJ, Metcalf D (1984) Expression of myb, myc, and fos proto-oncogenes during the differentiation of a murine myeloid leukemia. Nature 310:249–251PubMedCrossRefGoogle Scholar
  10. 10.
    Sheiness D, Gardinier M (1984) Expression of a protooncogene (proto-myb) in hematopoietic tissues of mice. Mol Cell Biol 4:1206–1212PubMedGoogle Scholar
  11. 11.
    Shen-Ong GLC, Morse III HD, Potter M, Mushinski JF (1986) Two modes of c-myb activation in virus-induced mouse myeloid tumors. Mol Cell Biol 6:380–392PubMedGoogle Scholar
  12. 12.
    Kanter MR, Smith RE, Hayward WS (1988) Rapid induction of B-cell lymphomas: insertional activation of c-myb by avian leukosis virus. J Virol 62:1423–1432PubMedGoogle Scholar
  13. 13.
    Torelli G, Venturelli D, Colo A, Zanni C, Selleri L, Moretti L, Calabretta B, Torelli U (1987) Expression of c-myb protooncogene and other cell cycle-related genes in normal and neoplastic human colonic musosa. Cancer Res 47:5266–5269PubMedGoogle Scholar
  14. 14.
    Thiele CJ, Cohen PS, Israel MA (1988) Regulation of c-myb expression in human neuroblastoma cells during retinoic acid-induced differentiation. Mol Cell Biol 8:1677–1683PubMedGoogle Scholar
  15. 15.
    Dyson PJ, Poirier F, Watson RJ (1989) Expression of c-myb in embryonal carcinoma cells and embryonal stem cells. Differentiation 42:24–27.PubMedCrossRefGoogle Scholar
  16. 16.
    Thiele CJ, McKeon C, Triche TJ, Ross RA, Reynolds CP, Israel MA (1987) Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system. J Clin Invest 80:804–811PubMedCrossRefGoogle Scholar
  17. 17.
    Alitalo K, Winquist R, Linn CC, de la Chapelle A, Schwab M, Bishop JM (1984) Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma. Proc Natl Acad Sci USA 81:4534–4538PubMedCrossRefGoogle Scholar
  18. 18.
    Griffin CA, Baylin SB (1985) Expression of the c-myb oncogene in human small cell lung carcinoma. Cancer Res 45:272–275PubMedGoogle Scholar
  19. 19.
    Slamon DJ, Boone TC, Murdock DC, Keith DE, Press MF, Lavson RA, Souza LM (1986) Studies of the human c-myb gene and its product in human acute leukemias. Science 233:347–354PubMedCrossRefGoogle Scholar
  20. 20.
    Slamon, DJ, deKernion JB, Verma IM, Cline MJ (1984) Expression of cellular oncogenes in human malignancies. Science 224:256–262PubMedCrossRefGoogle Scholar
  21. 21.
    Clarke, MF, Kukowska-Latallo JF, Westin E, Smith M, Prochownik EU (1988) Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol Cell Biol 8:884–8902PubMedGoogle Scholar
  22. 22.
    Weber BL, Westin EH, Clarke MF (1990) Differentiation of mouse erythroleukemia cells enhanced by alternatively spliced c-myb cDNA. Science 249:1291–1293PubMedCrossRefGoogle Scholar
  23. 23.
    Beug BL, Blundell P, Graf T (1987) Reversibility of differentiation and proliferative capacity in avian myelononocytic cells transformed by tsE26 leukemia virus. Genes Dev 1:277–286PubMedCrossRefGoogle Scholar
  24. 24.
    Calabretta B, Sims RS, Valtieri M, Caraccolo D, Szylik C, Venturelli D, Ratayzak M, Beran M, Gewirtz AM (1991) Normal and leukemic hemapoietic cell manifest differntial sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides in in vitro study relevant to bone marrow purging. Proc Natl Acad Sci USA 88:2351–2355PubMedCrossRefGoogle Scholar
  25. 25.
    Venturelli D, Mariano MT, Szylik C, Valteri M, Lange B, Crist W, Link M, Calabretta B (1990) Down-regulated c-myb expression inhibits DNA synthesis of T-leukemia cells in most patients. Cancer Res 50:7371–7375PubMedGoogle Scholar
  26. 26.
    Luscher B, Eisenman RN (1990) New light on myc and myb. Part II Myb. Genes Dev 4:2235–2241PubMedCrossRefGoogle Scholar
  27. 27.
    Frampton J, Leutz A, Gibson TJ, Graf T (1989) DNA binding domain ancestry. Nature 342:134PubMedCrossRefGoogle Scholar
  28. 28.
    Grosser FW, LaMontagne K, Whittaker L, Stohr S, Lipsick JS (1992) A highly conserved cysteine in the v-Myb DNA-binding domain is essential for transformation and transcriptional trans-activation. Oncogene 7:1005–1009Google Scholar
  29. 29.
    Ptashne M (1988) How eukaryotic transcriptional activators work. Nature 335:683–689PubMedCrossRefGoogle Scholar
  30. 30.
    Sakura H, Kanei-Ishii C, Nagase T, Nakagoshi H, Gonda T, Ishii S (1989) Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. Proc Natl Acad Sci USA 86:5758–5762PubMedCrossRefGoogle Scholar
  31. 31.
    Landschulz WH, Johnson PF, McKnight SL (1988) The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240:1759–1764PubMedCrossRefGoogle Scholar
  32. 32.
    Ness SA, Marknell A, Graf T (1989) The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene. Cell 59:1115–1125PubMedCrossRefGoogle Scholar
  33. 33.
    Evans JL, Moore TK, Keuhl WM, Bender T, Ting JPY (1990) Functional analysis of c-Myb protein in T-lymphocytic cell lines shows that it trans-activates the c-myc promoter. Mol Cell Biol 10:5747–5752PubMedGoogle Scholar
  34. 34.
    Siu G, Wuster AL, Lipsick JS, Hedrick SM (1992) Expression of the CD4 gene requires a MYB transcription factor. Mol Cell Biol 12:1592–1604PubMedGoogle Scholar
  35. 35.
    Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA, Pietryga DW, Scott Jr WJ, Potter SS (1991) A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65:677–689PubMedCrossRefGoogle Scholar
  36. 36.
    Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159PubMedCrossRefGoogle Scholar
  37. 37.
    Schmitt RM, Bruyns E, Snodgrass HR (1991) Hematopoietic development of embryonic stem cells in vitro: cytokine and receptor gene expression. Genes Dev 5:728–740PubMedCrossRefGoogle Scholar
  38. 38.
    Keller G, Kennedy M, Papyannopoulou T, Wiles MV (1993) Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol Cell Biol 13:473–486PubMedGoogle Scholar
  39. 39.
    McClanahan T, Dairymple, S, Barkett M, Lee F (1993) Hematopoietic growth factor receptor genes as markers of lineage commitment during in vitro development of hematopoietic cells. Blood 81:2903–2915PubMedGoogle Scholar
  40. 40.
    Spurr NK, Gough AC, Lee MG (1990) Cloning of the mouse homologue of the yeast cell cycle control gene. DNA Seq 1:49–54PubMedGoogle Scholar
  41. 41.
    Andrews NC, Erdjument-Bromage H, Davidson MB, Tempst P, Orkin SH (1993) Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature 362:722–728.PubMedCrossRefGoogle Scholar
  42. 42.
    Stanton LW, Fahrlander PD, Tesser PM, Marcu KB (1984) Nucleotide sequence comparison of normal and translocated murine c-myb genes. Nature 310:423–425PubMedCrossRefGoogle Scholar
  43. 43.
    Maniatis T, Fritsch EF, Sambrook J (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor, New York.Google Scholar
  44. 44.
    Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463–5467.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • H. H. Lin
    • 1
  • D. C. Sternfeld
    • 2
  • S. G. Shinpock
    • 3
  • R. A. Popp
    • 1
  • M. L. Mucenski
    • 3
  1. 1.University of Tennessee Graduate School of Biomedical SciencesOak RidgeUSA
  2. 2.DePauw UniversityGreencastleUSA
  3. 3.Biology DivisionOak Ridge National LaboratoryOak RidgeUSA

Personalised recommendations